BGM Group Ltd Ordinary Shares - Class A BGM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $8.59
- Day Range
- $8.65–8.94
- 52-Week Range
- $6.45–303.00
- Bid/Ask
- $8.60 / $10.75
- Shares Outstanding
- 13.35M
- Market Cap
- $115.51M
- Volume/Avg
- 2,848 / 6,253
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.39
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 471
- Website
- https://www.bgmgroupltd.com
Valuation
|
Metric
|
BGM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.18 |
Price/Sales | 1.39 |
Price/Cash Flow | 31.17 |
Price/Earnings
BGM
Financial Strength
|
Metric
|
BGM
|
|---|---|
Quick Ratio | 0.65 |
Current Ratio | 1.25 |
Interest Coverage | — |
Quick Ratio
BGM
Profitability
|
Metric
|
BGM
|
|---|---|
Return on Assets (Normalized) | −5.84% |
Return on Equity (Normalized) | −6.53% |
Return on Invested Capital (Normalized) | −6.49% |
Return on Assets
BGM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|CxDW^q> | LOCK|^Dvw% | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|!@RGtSBL | LOCK|YD$<^ | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|Q$m#<Q | LOCK|D$ | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|#f!cqM^ | LOCK|&D? | $33B | |||
| Viatris Inc
VTRS
| LOCK|$bH<s$r | LOCK|l@ | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|#H | LOCK|^@ | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|krXD@N | LOCK|>b | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|c<WCGqP | LOCK|LQf | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|q<Z^Z>z | LOCK|w<TYp | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|<%xP&gB | LOCK|sg? | $2B |
United States